Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?

Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?

Bibliographic Details
Main Authors:	Ramachandran Vignesh, Esaki M. Shankar
Format:	Article
Language:	English
Published:	Elsevier 2017-10-01
Series:	EBioMedicine
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352396417303420

Similar Items

24 Thalidomide reverses latency of HIV-1 provirus
by: S. Samer, et al.
Published: (2016-07-01)

23 Understanding the effects of latency reversing agents on HIV RNA splicing: implications for latency reversal
by: T.M. Mota, et al.
Published: (2016-07-01)

Forgive sins: rise of thalidomide
by: Yugandar Inakanti, et al.
Published: (2014-04-01)

Novel use of alprazolam as a potential HIV-1 latency reversing agent
by: W. Elbezanti, et al.
Published: (2017-12-01)

Combinatorial latency reversal activity of inhibitor of apoptosis antagonists with mechanistically distinct classes of HIV latency reversal agents
by: Shane D. Falcinelli, et al.
Published: (2019-12-01)

Optimisation of Smac mimetics as HIV-1 latency reversing agents
by: L. Pache, et al.
Published: (2019-12-01)

Approaches to discover latency-reversing agents
Published: (2015-12-01)

HIV latency reversing agents act through Tat post translational modifications
by: Georges Khoury, et al.
Published: (2018-05-01)

Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure
by: G. Clutton, et al.
Published: (2015-12-01)

HIV-1 Latency and Viral Reservoirs: Existing Reversal Approaches and Potential Technologies, Targets, and Pathways Involved in HIV Latency Studies
by: Sushant Khanal, et al.
Published: (2021-02-01)

Tissue-specific effects of latency-reversing agents on HIV transcriptional blocks in gut and blood
by: S. Telwatte, et al.
Published: (2019-07-01)

O3 Heme-arginate as a latency-reversing agent for HIV-1 cure
by: Michaela Madlenakova, et al.
Published: (2017-09-01)

Latency reversal agents modulate HIV antigen processing and presentation to CD8 T cells.
by: Julie Boucau, et al.
Published: (2020-03-01)

HIV Latency Reversing Agents have diverse effects on Natural Killer Cell Function
by: Carolina Garrido, et al.
Published: (2016-09-01)

Trade-off between synergy and efficacy in combinations of HIV-1 latency-reversing agents.
by: Vipul Gupta, et al.
Published: (2018-02-01)

Harmine enhances the activity of the HIV-1 latency-reversing agents ingenol A and SAHA
by: Jared P. Taylor, et al.
Published: (2020-12-01)

Diverse Impacts of HIV Latency-Reversing Agents on CD8+ T-Cell Function: Implications for HIV Cure
by: Genevieve Tyndale Clutton, et al.
Published: (2018-06-01)

Are we prepared to save the sanctity of science from predatory journals?
by: Vignesh Ramachandran, et al.
Published: (2019-01-01)

Synthesis and Biological Evaluation of Thalidomide Derivatives as Potential Anti-Psoriasis Agents
by: Kai-Wei Tang, et al.
Published: (2018-10-01)

Latency Reversing Agents: Kick and Kill of HTLV-1?
by: Annika P. Schnell, et al.
Published: (2021-05-01)

Identification of celastrol as a novel HIV-1 latency reversal agent by an image-based screen.
by: Hongbing Liu, et al.
Published: (2021-01-01)

Polyanionic carbosilane dendrimers as a new adjuvant in combination with latency reversal agents for HIV treatment
by: Ignacio Relaño-Rodríguez, et al.
Published: (2019-05-01)

Current Status of Latency Reversing Agents Facing the Heterogeneity of HIV-1 Cellular and Tissue Reservoirs
by: Amina Ait-Ammar, et al.
Published: (2020-01-01)

Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016-05-01)

Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents
by: D.A. Kulpa, et al.
Published: (2015-12-01)

New Latency Reversing Agents for HIV-1 Cure: Insights from Nonhuman Primate Models
by: Katherine M. Bricker, et al.
Published: (2021-08-01)

Are BET Inhibitors yet Promising Latency-Reversing Agents for HIV-1 Reactivation in AIDS Therapy?
by: Thanarat Salahong, et al.
Published: (2021-05-01)

The Right Ventricle—You May Forget It, But It Will Not Forget You
by: Patrick M. Wanner, et al.
Published: (2020-02-01)

HIV latency reversal using designed PKC modulators
by: M.D. Marsden, et al.
Published: (2017-12-01)

The Depsipeptide Romidepsin Reverses HIV-1 Latency In Vivo.
by: Ole S Søgaard, et al.
Published: (2015-09-01)

Reanalysis of Gene Expression Profiles of CD4+ T Cells Treated with HIV-1 Latency Reversal Agents
by: Antonio Victor Campos Coelho, et al.
Published: (2020-09-01)

Identification of Novel HIV-1 Latency-Reversing Agents from a Library of Marine Natural Products
by: Khumoekae Richard, et al.
Published: (2018-06-01)

Anti-latency agents to purge HIV reservoirs
by: Moreno Santiago
Published: (2012-05-01)

Identification of a promising new class of latency reversing agents
by: A. Gramatica, et al.
Published: (2017-12-01)

Reversible Pulmonary Hypertension Related to Thalidomide Treatment for Multiple Myeloma
by: Antonio Villa, et al.
Published: (2011-09-01)

Diverse effects of interferon alpha on the establishment and reversal of HIV latency.
by: Renée M Van der Sluis, et al.
Published: (2020-02-01)

Patient-derived HIV reservoirs can be stably engrafted into NSG mice and reactivated by latency-reversing agents in vivo
by: A. Ward, et al.
Published: (2017-12-01)

Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening
by: Donya Naz Divsalar, et al.
Published: (2020-06-01)

Combination of a Latency-Reversing Agent With a Smac Mimetic Minimizes Secondary HIV-1 Infection in vitro
by: Shin-ichiro Hattori, et al.
Published: (2018-09-01)

O6 Reactivation capacity by latency reversing agents ex vivo correlates with the size of the HIV-1 reservoir
by: Gilles Darcis, et al.
Published: (2016-09-01)